RGLS
RhumbLine Advisers’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,744
| Closed | -$101K | – | 4245 |
|
|
2025
Q1 | $101K | Sell |
57,744
-1,787
| -3% | -$3.13K | ﹤0.01% | 3388 |
|
|
2024
Q4 | $94.1K | Sell |
59,531
-14,964
| -20% | -$23.6K | ﹤0.01% | 3493 |
|
|
2024
Q3 | $117K | Sell |
74,495
-1,977
| -3% | -$3.1K | ﹤0.01% | 3457 |
|
|
2024
Q2 | $136K | Buy |
+76,472
| New | +$136K | ﹤0.01% | 3407 |
|
|
2017
Q2 | – | Sell |
-55,537
| Closed | -$92K | – | 2949 |
|
|
2017
Q1 | $92K | Buy |
55,537
+15,910
| +40% | +$26.4K | ﹤0.01% | 2783 |
|
|
2016
Q4 | $89K | Buy |
39,627
+3,165
| +9% | +$7.11K | ﹤0.01% | 2800 |
|
|
2016
Q3 | $120K | Buy |
36,462
+700
| +2% | +$2.3K | ﹤0.01% | 2789 |
|
|
2016
Q2 | $103K | Buy |
35,762
+8,720
| +32% | +$25.1K | ﹤0.01% | 2911 |
|
|
2016
Q1 | $187K | Buy |
27,042
+175
| +0.7% | +$1.21K | ﹤0.01% | 2754 |
|
|
2015
Q4 | $234K | Buy |
26,867
+1,600
| +6% | +$13.9K | ﹤0.01% | 2712 |
|
|
2015
Q3 | $165K | Buy |
25,267
+995
| +4% | +$6.5K | ﹤0.01% | 2856 |
|
|
2015
Q2 | $266K | Buy |
24,272
+9,700
| +67% | +$106K | ﹤0.01% | 2738 |
|
|
2015
Q1 | $247K | Buy |
14,572
+4,120
| +39% | +$69.8K | ﹤0.01% | 2720 |
|
|
2014
Q4 | $168K | Sell |
10,452
-475
| -4% | -$7.64K | ﹤0.01% | 2864 |
|
|
2014
Q3 | $75K | Hold |
10,927
| – | – | ﹤0.01% | 2948 |
|
|
2014
Q2 | $88K | Buy |
+10,927
| New | +$88K | ﹤0.01% | 2977 |
|